OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Inhibition of epigenetic reader proteins by apabetalone counters inflammation in activated innate immune cells from Fabry disease patients receiving enzyme replacement therapy
Li Fu, Sylwia Wasiak, Laura Tsujikawa, et al.
Pharmacology Research & Perspectives (2022) Vol. 10, Iss. 3
Open Access | Times Cited: 9
Li Fu, Sylwia Wasiak, Laura Tsujikawa, et al.
Pharmacology Research & Perspectives (2022) Vol. 10, Iss. 3
Open Access | Times Cited: 9
Showing 9 citing articles:
Epigenetics-targeted drugs: current paradigms and future challenges
Wanlin Dai, Xinbo Qiao, Yuanyuan Fang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 24
Wanlin Dai, Xinbo Qiao, Yuanyuan Fang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 24
Inflammation and Exosomes in Fabry Disease Pathogenesis
Bruna Coelho-Ribeiro, Helena Silva, Belém Sampaio‐Marques, et al.
Cells (2024) Vol. 13, Iss. 8, pp. 654-654
Open Access | Times Cited: 4
Bruna Coelho-Ribeiro, Helena Silva, Belém Sampaio‐Marques, et al.
Cells (2024) Vol. 13, Iss. 8, pp. 654-654
Open Access | Times Cited: 4
Bromodomain Proteins as New Drug Target for an Inborn Lysosomal Defect
Martina Parente, Amélie Barthelemy, Claudia Tonini, et al.
(2025)
Closed Access
Martina Parente, Amélie Barthelemy, Claudia Tonini, et al.
(2025)
Closed Access
Apabetalone (RVX-208): A Potential Epigenetic Therapy for the Treatment of Cardiovascular, Renal, Neurological, Viral, and Cancer Disorders
Hevna Dhulkifle, Mohammad Diab, Majed Ali Algonaiah, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 3, pp. 546-559
Open Access | Times Cited: 3
Hevna Dhulkifle, Mohammad Diab, Majed Ali Algonaiah, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 3, pp. 546-559
Open Access | Times Cited: 3
The role of tubular cells in the pathogenesis of Fabry nephropathy
Paula Rozenfeld, Sandro Feriozzi, Fabian Braun
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access | Times Cited: 1
Paula Rozenfeld, Sandro Feriozzi, Fabian Braun
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access | Times Cited: 1
Characterization and Proteomic Analyses of Proinflammatory Cytokines in a Mouse Model of Liver Transplant Rejection
Shipeng Li, Xinqiang Li, Xiaojie Chen, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-14
Open Access | Times Cited: 6
Shipeng Li, Xinqiang Li, Xiaojie Chen, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-14
Open Access | Times Cited: 6
Dual mechanism: Epigenetic inhibitor apabetalone reduces SARS-CoV-2 Delta and Omicron variant spike binding and attenuates SARS-CoV-2 RNA induced inflammation
Li Fu, Dean Gilham, Stephanie C. Stotz, et al.
International Immunopharmacology (2023) Vol. 117, pp. 109929-109929
Open Access | Times Cited: 3
Li Fu, Dean Gilham, Stephanie C. Stotz, et al.
International Immunopharmacology (2023) Vol. 117, pp. 109929-109929
Open Access | Times Cited: 3
Reversal of pathologic changes in fibroblasts from Niemann-Pick type C disease patients by inhibition of bromodomain and extraterminal proteins
Martina Parente, Amélie Barthelemy, Claudia Tonini, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Martina Parente, Amélie Barthelemy, Claudia Tonini, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
